114 related articles for article (PubMed ID: 17545041)
1. [Effects of two different antigen-loading methods on the activity of dendritic cell vaccine for colorectal carcinoma cell inhibition in vitro].
Huang H; Wang H; Wu ZQ; You CX; Luo RC; Yong L; Hermonat PL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):492-5. PubMed ID: 17545041
[TBL] [Abstract][Full Text] [Related]
2. [Killing effect of dendritic cell vaccine transfected by recombinant adeno-associated virus with hAFP gene fragment on hepatocellular carcinoma cells in vitro].
Sun JH; Ma YL; Peng ME; Bie AG; Li L; Liu L
Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):334-8. PubMed ID: 20723429
[TBL] [Abstract][Full Text] [Related]
3. [Development of a lung cancer vaccine by transfecting dendritic cells with rAAV/CEA].
You C; Qian X; He Y; Liu Y; Hermonat PL
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):487-91. PubMed ID: 24752093
[TBL] [Abstract][Full Text] [Related]
4. [GM-CSF gene-modified dendritic cell vaccine enhances antitumor immunity in vitro].
He SB; Sun K; Wang L; Li DC; Zhang YY
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):410-4. PubMed ID: 20819479
[TBL] [Abstract][Full Text] [Related]
5. [Dendritic cells infected by recombinant adeno-associated virus with CEA gene to induce antigen-specific CTL response to CD44(+)CD24(-/low) cells from MCF-7 breast cancer cell line].
Wang XL; Ma B; Jia J; Yuan YH; Yan Y; Di LJ; Song GH; Yu J; Ren J
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):173-8. PubMed ID: 21503107
[TBL] [Abstract][Full Text] [Related]
6. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
[TBL] [Abstract][Full Text] [Related]
7. Functional change of human peripheral blood monocyte-derived dendritic cells after recombinant adeno-associated virus type 2-mediated HBsAg gene infection.
Hu GF; Wu XB; Yu SY; Kang Y; Hou YD
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jul; 23(7):696-8, 701. PubMed ID: 12865224
[TBL] [Abstract][Full Text] [Related]
8. In vitro induction of specific anti-tumoral immunity against laryngeal carcinoma by using human interleukin-12 gene-transfected dendritic cells.
Liang W; Wang XF
Chin Med J (Engl); 2011 May; 124(9):1357-61. PubMed ID: 21740748
[TBL] [Abstract][Full Text] [Related]
9. Use and specificity of breast cancer antigen/milk protein BA46 for generating anti-self-cytotoxic T lymphocytes by recombinant adeno-associated virus-based gene loading of dendritic cells.
Liu Y; Chiriva-Internati M; You C; Luo R; You H; Prasad CK; Grizzi F; Cobos E; Klimberg VS; Kay H; Mehta JL; Hermonat PL
Cancer Gene Ther; 2005 Mar; 12(3):304-12. PubMed ID: 15565181
[TBL] [Abstract][Full Text] [Related]
10. Improvement of the cytotoxic T lymphocyte response against hepatocellular carcinoma by transduction of cancer cells with an adeno-associated virus carrying the interferon-γ gene.
Zhou J; Ma P; Li J; Cui X; Song W
Mol Med Rep; 2016 Apr; 13(4):3197-205. PubMed ID: 26936017
[TBL] [Abstract][Full Text] [Related]
11. [rAAV/BA46-transfected dendritic cells can induce specific cellular immunity].
You CX; Su J; Liao WJ; Zhang JY; Liu Y; Paul LH; Luo RC
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2146-9. PubMed ID: 19114342
[TBL] [Abstract][Full Text] [Related]
12. [An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma].
Gao J; Chen M; Peng ML; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):198-201. PubMed ID: 15760555
[TBL] [Abstract][Full Text] [Related]
13. rAAV/Her-2/neu loading of dendritic cells for a potent cellular-mediated MHC class I restricted immune response against ovarian cancer.
Yu Y; Pilgrim P; Zhou W; Gagliano N; Frezza EE; Jenkins M; Weidanz JA; Lustgarten J; Cannon M; Bumm K; Cobos E; Kast WM; Chiriva-Internati M
Viral Immunol; 2008 Dec; 21(4):435-42. PubMed ID: 19115932
[TBL] [Abstract][Full Text] [Related]
14. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Iida T; Yamaue H
Int J Oncol; 2008 Feb; 32(2):459-66. PubMed ID: 18202769
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients.
Lesterhuis WJ; De Vries IJ; Schreibelt G; Schuurhuis DH; Aarntzen EH; De Boer A; Scharenborg NM; Van De Rakt M; Hesselink EJ; Figdor CG; Adema GJ; Punt CJ
Anticancer Res; 2010 Dec; 30(12):5091-7. PubMed ID: 21187495
[TBL] [Abstract][Full Text] [Related]
16. Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Ishida K; Primus FJ; Yamaue H
Int J Cancer; 2007 Feb; 120(3):585-93. PubMed ID: 17096339
[TBL] [Abstract][Full Text] [Related]
17. An autologous therapeutic dendritic cell vaccine transfected with total lung carcinoma RNA stimulates cytotoxic T lymphocyte responses against non-small cell lung cancer.
Wang K; Zhou Q; Guo AL; Xu CR; An SJ; Wu YL
Immunol Invest; 2009; 38(7):665-80. PubMed ID: 19811429
[TBL] [Abstract][Full Text] [Related]
18. [Primary study on preparation and efficiency of neotype hepatocellular carcinoma-dendritic cell vaccine with SOCS1 expression inhibited].
Liu ZP; Zhang J; Lin P; Wang XJ; Wang Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):177-80. PubMed ID: 18630677
[TBL] [Abstract][Full Text] [Related]
19. Streptococcal preparation OK-432 promotes fusion efficiency and enhances induction of antigen-specific CTL by fusions of dendritic cells and colorectal cancer cells.
Koido S; Hara E; Homma S; Torii A; Mitsunaga M; Yanagisawa S; Toyama Y; Kawahara H; Watanabe M; Yoshida S; Kobayashi S; Yanaga K; Fujise K; Tajiri H
J Immunol; 2007 Jan; 178(1):613-22. PubMed ID: 17182602
[TBL] [Abstract][Full Text] [Related]
20. Enhanced induction of anti-tumor CTLs in vitro by a lentivirus-transduced dendritic cell vaccine expressing secondary lymphoid tissue chemokine and mucin 1.
Wang B; Zhu Y; Zhang JJ; Chen Z; Liang WB; Xu ZK
Asian Pac J Cancer Prev; 2011; 12(11):2811-7. PubMed ID: 22393946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]